Ono Pharmaceutical Q2 GAAP EPS of ¥95.60, revenue of ¥232.5B

Resumen del corpus

Ono Pharmaceutical reported GAAP EPS of ¥95.60 and revenues of ¥232.5B in the second quarter. Operating profit grew 11.2% year-over-year to ¥57.91B, and core operating profit increased by 5.1% year-over-year to ¥73.63B. Consolidated forecasts for the full fiscal year ending March 31, 2027, project revenues of ¥455.00B and operating profit of ¥94.00B under IFRS.